Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ETEarth Science Tech, Inc. logo

Earth Science Tech, Inc. (ETST)

Other OTC · Currency in USD
$0.09 ▲ +0.00 (+5.22%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.09
Open
$0.09
Day's Range
$0.09 – $0.09
52 Week Range
$0.00 – $0.24
Volume
13,241
Avg. Volume
100,587
Market Cap
$27.23M
Beta (5Y Monthly)
2.47
PE Ratio (TTM)
7.12
EPS (TTM)
$0.01
Earnings Date
Nov 11, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Earth Science Tech, Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
77
CEO
Giorgio R. Saumat

Earth Science Tech, Inc. (EST) is a biotechnology firm dedicated to the worldwide development and distribution of nutraceuticals, bioceuticals, and dietary supplements. These offerings aim to support general health, overall well-being, nutrition, and address specific needs within the cosmetic and alternative medicine sectors. The company's nutritional and dietary supplements are specifically formulated to help manage a wide range of conditions, including chronic and joint discomfort, inflammation, seizures, hypertension, cognitive decline, mood imbalances, weight management, nausea, and the physiological effects of aging, while also promoting overall vitality.

Earnings

Next report: Wed, Nov 11, 2026
DateEst.Actual
Aug 7, 2026–$0.00
Jun 18, 2026$0.01$0.01Beat
Feb 13, 2026$0.01$0.00Miss
Nov 12, 2025–$0.00
Aug 8, 2025–$0.00
Jun 26, 2025–$0.00

Get free alerts on ETST and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.